07:30 AM EDT, 05/13/2024 (MT Newswires) -- Legend Biotech ( LEGN ) reported a Q1 net loss Monday of $0.16 per diluted share, compared with a loss of $0.34 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.18 per share.

Total revenue for the quarter ended March 31 was $94 million, up from $36.3 million a year earlier.

Analysts surveyed by Capital IQ expected $141.4 million.

Legend Biotech ( LEGN ) shares were up more than 10% in Monday's premarket activity.

Price: 47.73, Change: +4.49, Percent Change: +10.38